29 computer-programmer-"https:"-"https:"-"RMIT-UNIVERSITY" Fellowship positions at UNIVERSITY OF SOUTHAMPTON
Sort by
Refine Your Search
-
We are seeking a computational glycobiologist to join a multidisciplinary project developing next-generation enzymatic tools for antibody glycoengineering. The role will focus on applying state
-
. The successful candidate will contribute to an interdisciplinary research programme developing computational models to understand molecular interactions relevant to antimicrobial systems, biomolecular interfaces
-
The Faculty of Medicine Genomic Informatics Group invites applications for a 3-year full time fixed-term postdoctoral position of Research Fellow or Senior Research Fellow in Genomic Informatics to
-
) Country United Kingdom Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a
-
Growth of Functional 1D and 2D Metal Dichalcogenide Semiconductors) Programme Grant recently announced by the UK Engineering and Physical Sciences Research Council (EPSRC). EXPRESS is a large (£10M
-
Precursors for the Electrochemical Growth of Functional 1D and 2D Metal Dichalcogenide Semiconductors) Programme Grant recently announced by the UK Engineering and Physical Sciences Research Council (EPSRC
-
provided. The post will be at registrar level and will require a medical qualification. It would be suitable for a trainee with relevant experience in paediatric medicine as out of program experience
-
programme, Deep Molecular Phenotyping of Metastatic Breast Cancer. This ambitious, interdisciplinary project aims to generate an integrated, multi-omic understanding of secondary (metastatic) breast cancer
-
candidate will contribute to an interdisciplinary research programme focused on the design, synthesis, and characterisation of liquid metal nanomaterials as catalytic artificial enzymes for biomedical and
-
postdoctoral scientist to work on our Blood Cancer UK-funded programme developing next-generation, off-the-shelf immunotherapies for acute myeloid leukaemia (AML). This three-year project will harness cytotoxic